HeraMED Ltd. (1I4) Financial Statements
HeraMED Ltd. Financial Overview
HeraMED Ltd.'s market cap is currently $26.99M. The company's EPS TTM is $-0.00; its P/E ratio is -11.83; HeraMED Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 195.77K | $ 225.49K | $ 413.19K | $ 215.81K | $ 83.68K |
| Gross Profit | $ 99.78K | $ 135.29K | $ 248.12K | $ -214.69K | $ -219.50K |
| Operating Income | $ -2.66M | $ -5.57M | $ -4.55M | $ -3.17M | $ -3.93M |
| EBITDA | $ -2.56M | $ -3.15M | $ -3.97M | $ -2.83M | $ -3.67M |
| Net Income | ― | $ -3.40M | $ -4.50M | $ -4.88M | $ -5.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 914.65K | $ 3.13M | $ 723.29K | $ 2.64M | $ 3.55M |
| Total Assets | $ 994.94K | $ 2.78M | $ 2.01M | $ 4.19M | $ 4.57M |
| Total Debt | $ 282.39K | $ 815.96K | $ 209.37K | $ 179.53K | $ 3.41M |
| Net Debt | $ -632.27K | $ -2.31M | $ -513.92K | $ -2.46M | $ -140.48K |
| Total Liabilities | $ 559.96K | $ 1.06M | $ 1.55M | $ 1.30M | $ 4.13M |
| Stockholders' Equity | $ 621.27K | $ 1.72M | $ 466.70K | $ 2.88M | $ -105.66K |
| Cash Flow | |||||
| Free Cash Flow | $ -2.44M | $ -2.98M | $ -5.57M | $ -3.20M | $ -3.20M |
| Operating Cash Flow | $ -2.44M | $ -4.81M | $ -5.57M | $ -2.56M | $ -3.23M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -2.05K | $ -690.78K | $ -85.43K |
| Financing Cash Flow | $ 1.27M | $ 6.88M | $ 2.96M | $ 2.54M | $ 4.88M |
Currency in USD
